Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/221581


Analgesics in France


Description: The Analgesics in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: adult analgesics, child-specific analgesics, systemic analgesics, topical analgesics

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?
- Get a detailed picture of the analgesics industry
- Pinpoint growth sectors and trends and identify factors driving change
- Understand the competitive environment, the market’s major players and leading brands
- Use five-year forecasts to assess how the market is predicted to develop


Contents: Analgesics in France
Euromonitor International
April 2009
List of Contents and Tables
Executive Summary
OTC Healthcare Suffers From Consumers Obtaining More Prescription Products
Increasing Presence of Self-service Areas in Chemists/pharmacies for OTC Products
A Fragmented Market Led by OTC Manufacturers
Chemists/pharmacies Remains the Leading Distribution Channel
Positive Performance Through the Development of Self-medication
Key Trends and Developments
the Setting-up of Self-service: Its Impact on Self-medication
Vitamins and Dietary Supplements for Everyone
the Grey Market Is the New Key Target Consumer Group
Decreasing Purchasing Power Favours Rx Products
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
Market Data
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
Vitamins & Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 Rx-to-OTC Healthcare Switches 2006-2008
Definitions
Summary 2 Research Sources
Arkopharma Sa, Laboratoires Pharmaceutiques
Strategic Direction
Key Facts
Summary 3 Laboratoires Pharmaceutiques Arkopharma SA: Key Facts
Summary 4 Laboratoires Pharmaceutiques Arkopharma SA: Operational Indicators
Company Background
Competitive Positioning
Summary 5 Laboratoires Pharmaceutiques Arkopharma SA: Competitive Position 2008
Beaufour-ipsen SA
Strategic Direction
Key Facts
Summary 6 Beaufour-Ipsen SA: Key Facts
Summary 7 Beaufour-Ipsen SA: Operational Indicators
Company Background
Production
Summary 8 Beaufour-Ipsen SA: Production Statistics 2007
Competitive Positioning
Summary 9 Beaufour-Ipsen SA: Competitive Position 2008
Cooper SA
Strategic Direction
Key Facts
Summary 10 Cooper SA: Key Facts
Summary 11 Cooper SA: Operational Indicators
Company Background
Production
Summary 12 Cooper SA: Production Statistics 2007
Competitive Positioning
Summary 13 Cooper SA: Competitive Position 2008
GlaxoSmithKline Santé Grand Public Sas
Strategic Direction
Key Facts
Summary 14 GlaxoSmithKline Santé Grand Public SAS: Key Facts
Summary 15 GlaxoSmithKline Santé Grand Public SAS: Operational Indicators
Company Background
Production
Summary 16 GlaxoSmithKline France: Production Statistics 2007
Competitive Positioning
Summary 17 GlaxoSmithKline Santé Grand Public SAS: Competitive Position 2008
Juva Santé, Laboratoires
Strategic Direction
Key Facts
Summary 18 Laboratoires Juva Santé: Key Facts
Summary 19 Laboratoires Juva Santé: Operational Indicators
Company Background
Production
Summary 20 Laboratoires Juva Santé: Production Statistics 2006
Competitive Positioning
Summary 21 Laboratoires Juva Santé: Competitive Position 2008
Laboratoires Mcneil
Strategic Direction
Key Facts
Summary 22 Laboratoires McNeil: Key Facts
Summary 23 Laboratoires McNeil: Operational Indicators
Company Background
Competitive Positioning
Summary 24 Laboratoires McNeil: Competitive Position 2008
Pierre Fabre Sa, Laboratoires
Strategic Direction
Key Facts
Summary 25 Laboratoires Pierre Fabre SA: Key Facts
Summary 26 Laboratoires Pierre Fabre SA: Operational Indicators
Company Background
Production
Summary 27 Laboratoires Pierre Fabre SA: Production Statistics 2007
Competitive Positioning
Summary 28 Laboratoires Pierre Fabre SA: Competitive Position 2008
Théraplix SA
Strategic Direction
Key Facts
Summary 29 Théraplix SA: Key Facts
Company Background
Competitive Positioning
Summary 30 Théraplix SA: Competitive Position 2008
Upsa, Laboratoires
Strategic Direction
Key Facts
Summary 31 Laboratoires UPSA: Key Facts
Summary 32 Laboratoires UPSA: Operational Indicators
Company Background
Production
Summary 33 UPSA Conseil SAS: Production Statistics 2007
Competitive Positioning
Summary 34 UPSA Conseil SAS: Competitive Position 2008
Urgo, Laboratoires
Strategic Direction
Key Facts
Summary 35 Laboratoires Urgo: Key Facts
Summary 36 Laboratoires Urgo: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 37 Laboratoires Urgo: Competitive Position 2008
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 12 Sales of Analgesics by Subsector: Value 2003-2008
Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 14 Herbal vs Standard Topical Analgesics 2003-2008
Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 16 Analgesics Company Shares by Value 2004-2008
Table 17 Analgesics Brand Shares by Value 2005-2008
Table 18 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013


Summary: Semi-ethical sales
France is a market where the influence of semi ethical product sales on the market as a whole is significant. Although the French government has been involved in de-listing initiatives, the French national health service continues to offer a wide range of products which can be reimbursed by the state. At a time of relative economic hardship, this represents a very attractive option for a considerable number of consumers.


Companies Mentioned Companies Mentioned Include: - UCB-Pharma - Laboratoires Bouchara-Recordati - Laboratoires Schering-Plough - UPSA, Laboratoires - Théraplix SA - Laboratoires Roche Nicholas SAS - Pierre Fabre SA, Laboratoires - Urgo, Laboratoires - Sanofi-Synthélabo France SA - GlaxoSmithKline Santé Grand Public SAS - Laboratoires Martin-Johnson & Johnson-MSD SAS - Beaufour-Ipsen SA - Pfizer Santé Grand Public - Arkopharma SA - Ricola AG - Juva Santé, Laboratoires - Boots Healthcare International Ltd - Whitehall Laboratories Ltd - Pharmacia SNC - Laboratoires du Docteur E Bouchara - Janssen Cilag - Lachartre, Laboratoire - Novartis Group France SA - Beiersdorf SA - Boehringer Ingelheim France SAS - Laboratoires Mercurochrome - Solvay Pharma - Viatris GmbH - Gifrer Barbezat SA - Laboratoire Oenobiol - Orgamol SA - Cadbury France SA - Bayer Pharma SA - Monot, Laboratoires - Biogalénique RPG - Cooper SA - Menarini France SA - Laboratoires Physcience - Reckitt Benckiser France SA - Johnson & Johnson Consumer France SAS - Therval Médical - Lofthouse of Fleetwood Ltd - Jolly-Jattel SARL - Biocodex SA, Laboratoires - Vitarmonyl, Laboratoires - Mayoly Spindler, Laboratoires - Pharmygiène, Laboratoires - Chauvin SA, Laboratoires - Plantes et Médecines, Laboratoires - Ferring Legemidler AS - Merck Médication Familiale SAS - Medix, Laboratoires - Asta Médica SA - Laboratoires HRA Pharma SA - Alcon France SA, Laboratoires - CIBA Vision SAS - Laboratoires UPSA - Etris SA, Laboratoires - LEA Institut Vital, Groupe Naturland - Ardeval-Chefaro - CS Laboratoires SA - Laboratoires Juva Santé - Roche-Posay SA, Laboratoire - Altana Pharma SA - Stiefel SARL, Laboratoires - Jouveinal, Groupe - Sarget, Laboratoire - Vichy SA, Laboratoire Industriel de (LIDV) EG Labo - Médipha Santé SAS - Brothier, Laboratoires - Norgine Pharma - LaboratoireThéramex SAM - Santé Beauté SA, Laboratoires - Clément, Laboratoires - Biapharm SAS - Byk France SA


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/221581

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 27/11/2009 04:01:19
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Analgesics in France
Web Address:
http://www.researchandmarkets.com/reports/221581
Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €675.00
Electronic (PDF) - Site License €1,350.00
Electronic (PDF) - Enterprisewide €2,025.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 27/11/2009 04:01:19

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)